Literature DB >> 32208011

Placenta Accreta Spectrum: Correlation of MRI Parameters With Pathologic and Surgical Outcomes of High-Risk Pregnancies.

Haley R Clark1, Timothy W Ng1, Ambereen Khan1, Sarah Happe2, Jodi Dashe2, Yin Xi1, Diane M Twickler1.   

Abstract

OBJECTIVE. The purpose of this study is to determine whether MRI parameters of placenta accreta spectrum correlate with pathologic and surgical outcomes in high-risk pregnancies. MATERIALS AND METHODS. This retrospective study evaluated second- and third-trimester pregnancies assessed by MRI from 2007 to the present. Women were included in the study if placental invasion was suspected on the basis of a clinical history of cesarean delivery, ultrasound findings, or both. MR images were reviewed by an experienced radiologist who was blinded to the clinical outcomes. Eighteen MRI parameters were assessed and compared with four clinical outcomes: surgical impression of invasion, need for cesarean hysterectomy, pathologic findings, and need for blood transfusion. RESULTS. Of 64 women, 43 required cesarean hysterectomy, 20 underwent cesarean delivery, and one delivered vaginally. There was no statistical difference among the women in terms of maternal age, gestational age, or the number of prior cesarean deliveries. Eight of the 18 MRI parameters assessed showed statistical significance. The five variables with the highest odds ratios were bulge (7.432), placenta previa (7.283), low-attenuation T2 linear bands (5.985), placental heterogeneity near the scar (4.384), and fibrin deposition (4.322), with additional significant variables including interruption of the bladder-serosa interface, the radiologist's interpretation of invasion, and the largest dimension of invasion. Some previously described parameters, such as the degree of maternal pelvic vascularity, were not statistically significant. CONCLUSION. MRI parameters are associated with placental invasion and correlate with the need for cesarean hysterectomy, as well as pathologic and surgical impressions of invasion. From these parameters, an organized template can be created to standardize reporting of placental invasion.

Entities:  

Keywords:  MRI; invasion; placenta accreta

Year:  2020        PMID: 32208011     DOI: 10.2214/AJR.19.21705

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  5 in total

1.  Diagnostic performance of radiologists with different levels of experience in the interpretation of MRI of the placenta accreta spectrum disorder.

Authors:  Caroline Lorenzoni Almeida Ghezzi; Cristiano Kohler Silva; Aline Spader Casagrande; Stephanie Sander Westphalen; Cristiano Caetano Salazar; Janete Vettorazzi
Journal:  Br J Radiol       Date:  2021-09-24       Impact factor: 3.039

2.  Assessing reproducibility in Magnetic Resonance (MR) Radiomics features between Deep-Learning segmented and Expert Manual segmented data and evaluating their diagnostic performance in Pregnant Women with suspected Placenta Accreta Spectrum (PAS).

Authors:  Yin Xi; Maysam Shahedi; Quyen N Do; James Dormer; Matthew A Lewis; Baowei Fei; Catherine Y Spong; Ananth J Madhuranthakam; Diane M Twickler
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2021-02-15

3.  The Volume of T2 Low-Signal Band and the Width of the Widest Blood Vessel in Placenta Measured by MRI in Pregnant Women with Different Types of Placental Implantation and Its Differential Value.

Authors:  Jun Duan; Jianqiang Su; Yun Zhang; Like Ma; Liang Zhao
Journal:  Comput Math Methods Med       Date:  2022-04-21       Impact factor: 2.809

4.  Application of Ultrasound Combined with Magnetic Resonance Imaging in the Diagnosis and Grading of Patients with Prenatal Placenta Accreta.

Authors:  Xiaoyan Zhang; Fengfeng Liu; Xiaoyan Wang
Journal:  Scanning       Date:  2022-07-22       Impact factor: 1.750

5.  Prediction for Postpartum Hemorrhage of Placenta Previa Patients through MRI Using Self-Adaptive Edge Detection Algorithm.

Authors:  Yan Chen; Ting Xu
Journal:  Contrast Media Mol Imaging       Date:  2021-08-26       Impact factor: 3.161

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.